Calliditas Therapeutics AB
NASDAQ:CALT
Calliditas Therapeutics AB
NASDAQ:CALT
Price:
40.0001
USD
Market Closed
Market Cap:
$1.1B
Balance Sheet
Balance Sheet Decomposition
Calliditas Therapeutics AB
Calliditas Therapeutics AB
Balance Sheet Decomposition is not available for
Calliditas Therapeutics AB
Calliditas Therapeutics AB
Balance Sheet
Calliditas Therapeutics AB
Calliditas Therapeutics AB
Currency: SEK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
25
|
24
|
57
|
646
|
754
|
996
|
956
|
1 249
|
974
|
|
| Cash |
25
|
24
|
57
|
646
|
754
|
996
|
956
|
1 249
|
974
|
|
| Total Receivables |
2
|
2
|
4
|
2
|
49
|
23
|
11
|
81
|
188
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
47
|
0
|
0
|
81
|
188
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
3
|
23
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
20
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
18
|
18
|
45
|
78
|
93
|
|
| Total Current Assets |
28
|
27
|
62
|
648
|
821
|
1 037
|
1 013
|
1 412
|
1 275
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
6
|
5
|
40
|
32
|
54
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
6
|
5
|
40
|
32
|
54
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
2
|
4
|
5
|
19
|
8
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
16
|
461
|
399
|
438
|
431
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
49
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
17
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
2
|
2
|
4
|
7
|
8
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
14
|
26
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
49
|
|
| Total Assets |
28
N/A
|
27
-3%
|
62
+128%
|
648
+941%
|
845
+30%
|
1 506
+78%
|
1 460
-3%
|
1 953
+34%
|
1 859
-5%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
3
|
5
|
14
|
23
|
24
|
54
|
68
|
160
|
101
|
|
| Accrued Liabilities |
6
|
6
|
14
|
7
|
26
|
41
|
54
|
136
|
281
|
|
| Short-Term Debt |
0
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
4
|
10
|
10
|
13
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
1
|
6
|
4
|
18
|
13
|
|
| Total Current Liabilities |
10
|
42
|
29
|
30
|
53
|
106
|
135
|
325
|
407
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
4
|
1
|
213
|
729
|
967
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
80
|
31
|
40
|
42
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
46
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
64
|
72
|
93
|
109
|
|
| Total Liabilities |
10
N/A
|
42
+314%
|
29
-30%
|
30
+4%
|
57
+89%
|
296
+418%
|
452
+53%
|
1 187
+163%
|
1 524
+28%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
176
|
233
|
320
|
456
|
488
|
925
|
1 454
|
1 836
|
2 306
|
|
| Additional Paid In Capital |
194
|
218
|
353
|
1 072
|
1 275
|
2 133
|
2 460
|
2 591
|
2 643
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
5
|
|
| Total Equity |
18
N/A
|
14
N/A
|
33
N/A
|
618
+1 763%
|
788
+27%
|
1 210
+54%
|
1 008
-17%
|
766
-24%
|
335
-56%
|
|
| Total Liabilities & Equity |
28
N/A
|
27
-3%
|
62
+128%
|
648
+941%
|
845
+30%
|
1 506
+78%
|
1 460
-3%
|
1 953
+34%
|
1 859
-5%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
33
|
33
|
33
|
35
|
39
|
50
|
52
|
54
|
54
|
|
Switch to:
Switch to:
See Also
Discover More
